Trevi Therapeutics (TRVI) Tops Q4 EPS by 2c
Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.